Blueblood Ventures Limited

BVL6

INE562S01013

Investment Banking & Brokerage Services

Market Closed - Bombay S.E. Other stock markets 06:00:56 2023-05-29 am EDT			5-day change	1st Jan Change
11.07 ^INR	+4.93%		-.--%	-.--%

2023	Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
2023	BlueBlood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2023	CI

BlueBlood Ventures Limited Appoints Narsimha Kavadi as Independent Director

May 29, 2019 at 11:24 am EDT

BlueBlood Ventures Limited at its Board Meeting held on May 29, 2019, approved the appointment of Mr. Narsimha Kavadi as an Independent Director.

Latest news about Blueblood Ventures Limited

Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 14	CI
BlueBlood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-09-11	CI
BlueBlood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-14	CI
BlueBlood Ventures Limited Approves Amit Kumar Lal Not Standing for Re-Election	22-09-30	CI
BlueBlood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-30	CI
BlueBlood Ventures Limited Announces Appointment of Jatin Bhatia as Company Secretary and Compliance Officer	22-02-24	CI
BlueBlood Ventures Limited Announces Resignation of Palak Chopra as Company Secretary and Compliance Officer	22-02-24	CI
BlueBlood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-13	CI
Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2021	21-06-28	CI
BlueBlood Ventures Limited Announces Resignation of Raman Rastogi as Company Secretary & Compliance Officer	21-06-17	CI
BlueBlood Ventures Limited Announces Resignation of Manjeet Pugalia as Independent Director	21-01-19	CI
Blueblood Ventures Limited Announces Resignation of Neha Bansal as Company Secretary and Compliance Officer	20-12-07	CI
Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2020	20-11-12	CI
BlueBlood Ventures Limited Announces Board Changes	20-09-04	CI
Blueblood Ventures Limited Reports Earnings Results for the Full Year Ended March 31, 2020	20-07-31	CI
Blueblood Ventures Limited Reports Earnings Results for the Half Year Ended September 30, 2019	19-11-29	CI
BlueBlood Ventures Limited Announces Regularization of Appointment of Narsimha Kavadi as an Independent Non-Executive Director	19-09-04	CI
Blueblood Ventures Limited Announces Audited Standalone Earnings Results for the Half Year and Full Year Ended March 31, 2019	19-05-29	CI
BlueBlood Ventures Limited Appoints Narsimha Kavadi as Independent Director	19-05-29	CI
600,216 Equity Shares of BlueBlood Ventures Limited are subject to a Lock-Up Agreement Ending on 3-FEB-2019.	19-02-02	CI
BlueBlood Ventures Limited cancelled the acquisition of 99.99% stake in Fullerton Securities & Wealth Advisors Limited from Angelica Investments Pte. Ltd.	18-12-15	CI
BlueBlood Ventures Limited Announces Standalone Unaudited Earnings Result for the Half Year Ended September 30, 2018	18-11-14	CI
Blueblood Ventures Limited Appoints Suresh Bohra as Chief Financial Officer	18-09-29	CI
BlueBlood Ventures Limited Announce Executive Changes	18-05-28	CI
Blueblood Ventures Limited Announces Audited Standalone Earnings Results for the Half Year and Full Year Ended March 31, 2018	18-05-28	CI

Chart Blueblood Ventures Limited

Duration

Period

More charts

Blueblood Ventures Limited is an India-based company that is engaged in the business of security and commodity contracts brokerage, and management consultancy activities. The Company is involved in the business of equity investment and trading in equity, derivatives, currencies, venture capital funding, commodities, futures and options, as well as other financial products. The Company is also engaged in investment in real estate segment.

Sector

Investment Banking & Brokerage Services

Calendar

2024-05-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Investment Banking & Brokerage Services

	1st Jan change	Capi.
BLUEBLOOD VENTURES LIMITED	-.--%	398K
MORGAN STANLEY	+7.96%	162B
THE GOLDMAN SACHS GROUP, INC.	+20.10%	156B
CHARLES SCHWAB	+12.86%	141B
CITIGROUP INC.	+24.19%	121B
CITIC SECURITIES COMPANY LIMITED	-6.68%	36.47B
RAYMOND JAMES FINANCIAL, INC.	+15.08%	26.32B
CSC FINANCIAL CO., LTD.	-4.64%	21.31B
LPL FINANCIAL HOLDINGS INC.	+16.81%	20.05B
NOMURA HOLDINGS, INC.	+39.17%	16.84B

Other Investment Banking & Brokerage Services